Table 3. Multiple-adjusted analysis for OS and DSS among the whole population (n = 2433).
Variables | OS | DSS | ||||
HR | 95% CI | P | HR | 95% CI | P | |
Age, years | <0.001 | <0.001 | ||||
<46 | Ref | Ref | ||||
≥46 | 1.83 | 1.58–2.12 | 1.65 | 1.40–1.96 | ||
Sex | <0.001 | <0.001 | ||||
Male | Ref | Ref | ||||
Female | 0.68 | 0.57–0.82 | 0.69 | 0.56–0.86 | ||
UICC T Stage | <0.001 | <0.001 | ||||
T1–T2 | Ref | Ref | ||||
T3–T4 | 1.35 | 1.17–1.57 | 1.34 | 1.13–1.59 | ||
UICC N Stage | <0.001 | <0.001 | ||||
N0–N1 | Ref | Ref | ||||
N2–N3 | 1.44 | 1.23–1.67 | 1.45 | 1.21–1.74 | ||
Treatment | 0.049 | 0.064 | ||||
RT | Ref | Ref | ||||
RT+CT | 1.18 | 1.00–1.38 | 1.23 | 1.02–1.49 | ||
BMI+Weight loss(2×3 groups) | <0.001† | <0.001† | ||||
NW+LWL | Ref | Ref | ||||
NW+HWL | 1.45 | 1.18–1.78 | <0.001 | 1.57 | 1.22–2.01 | <0.001 |
UW+LWL | 1.25 | 0.89–1.75 | 0.191 | 1.23 | 0.80–1.88 | 0.348 |
UW+HWL | 2.56 | 1.65–3.56 | <0.001 | 2.66 | 1.82–3.88 | <0.001 |
OW+LWL | 0.82 | 0.64–1.05 | 0.116 | 0.90 | 0.67–1.22 | 0.501 |
OW+HWL | 0.98 | 0.79–1.22 | 0.881 | 1.08 | 0.83–1.40 | 0.577 |
Footnote: Ref, reference; HR, hazard ratio.
result of joint test.